Company Overview of Cebix Incorporated
Cebix Incorporated is a biopharmaceutical company that focuses on the treatment of diabetic complications, including those affecting the function of nerves, kidneys, and eyes. The company develops Ersatta, a disease-modifying replacement peptide for the treatment of complications associated with diabetes. Its Ersatta is a once-weekly C-peptide therapy to target loss of nerve function and other vascular complications in Type 1 diabetes patients. The company was incorporated in 2008 and is based in San Diego, California.
12520 High Bluff Drive
San Diego, CA 92130
Founded in 2008
Key Executives for Cebix Incorporated
Cebix Incorporated Key Developments
Similar Private Companies By Industry
|Nutratech, Inc.||United States|
|Fournier Pharma Corp.||United States|
|King Pharmaceuticals LLC||United States|
|Cardero Therapeutics, Inc.||United States|
|Supplements Liquidating Trust, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Cebix Incorporated, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.